Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,867 signal articles · 185 in last 24h · 157,418 total before filter · latest 58m ago
185last 24h
866last 7d
140● bullish (7d)
81● bearish (7d)
214publishers
AllMacro199Earnings138M&A102Regulatory18Product20Analyst23
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
BlackRock (BLK) Launches LifePath Solutions As Undervalued Narrative Stays In Focus
Simply Wall St.9d agoneutral
BlackRock (BLK) Launches LifePath Solutions As Undervalued Narrative Stays In Focus

BlackRock (BLK) has put retirement design back in focus after unveiling LifePath Solutions, a customizable target date framework that blends public and private markets, guaranteed income options, and participant level analysis for workplace plans. Against this backdrop, BlackRock’s shares trade at US$1,069.78, with a 1 day share price return of 1.50% following a recent 30 day share price decline of 7.69% and a 90 day share price gain of 1.88%. This sits alongside a 3 year total shareholder...

Bank of New York Mellon Corporation (BNY) Lost A Depositary Mandate
Simply Wall St.9d agoneutral
Bank of New York Mellon Corporation (BNY) Lost A Depositary Mandate

Bank of New York Mellon Corporation (NYSE:BNY) has been replaced as depositary for Kazia Therapeutics Limited’s American Depositary Receipt program. Kazia Therapeutics has appointed JPMorgan Chase Bank, N.A. as the new depositary for its ADRs, according to the company’s latest update. The shift away from Bank of New York Mellon Corporation in Kazia’s ADR program highlights a change in a visible client mandate for BNY’s capital markets services. The replacement of Bank of New York Mellon...

Why Did Iovance Biotherapeutics (IOVA) Move Today?
Simply Wall St.9d agoneutral
Why Did Iovance Biotherapeutics (IOVA) Move Today?

Iovance Biotherapeutics (IOVA) shares have been active after the company reported record second quarter revenue of nearly US$100 million and a 56% margin, alongside broader plans for its tumor infiltrating lymphocyte platform. Iovance Biotherapeutics has seen momentum build quickly, with a 90-day share price return of 162.15% and a year-to-date share price gain of 306.75%. The 1-year total shareholder return of 400% contrasts with a 5-year total shareholder return that remains down...

Power Solutions International (PSIX) Rebounds Sharply, Is It Still 35% Below Fair Value?
Simply Wall St.9d agoneutral
Power Solutions International (PSIX) Rebounds Sharply, Is It Still 35% Below Fair Value?

Power Solutions International (PSIX) has drawn fresh attention after recent share price moves, with the stock up around 26% over the past month and about 14% over the past 3 months. Even after the recent 26.4% 1 month share price return and an 8.9% move over the past week, Power Solutions International is still down about 25.5% on a year to date share price basis. The 1 year total shareholder return has fallen 58.3%, despite a very large 3 year total shareholder return and strong 5 year total...

AutoZone (AZO) Stock Fair Value Edges Lower After Analysts Trim Price Targets
Simply Wall St.9d agoneutral
AutoZone (AZO) Stock Fair Value Edges Lower After Analysts Trim Price Targets

AutoZone is in focus after analysts modestly trimmed their implied valuation ranges, with updated price targets now clustered around US$3,450 to US$3,637 compared with prior levels that pointed closer to US$3,867.91. These moves are tied to a more cautious tone on near term execution, especially around comparable sales and pressure on the do it yourself customer, even as some firms still outline a longer term case for the stock. Read on to see how these shifting targets fit into the broader...

General Motors (GM) Stock Could Be 40% Undervalued After Digital Business Optimism
Simply Wall St.9d agoneutral
General Motors (GM) Stock Could Be 40% Undervalued After Digital Business Optimism

General Motors has delivered a strong multi‑year return for shareholders. The question now is whether the current US$82.20 share price is adequately supported by the cash the business is expected to generate. With fresh attention on its software, battery and driver assistance plans, investors are asking if the recent market optimism lines up with the company’s underlying cash flow profile. General Motors has returned 160.0% over the past 3 years, which makes the link between that share price...

Axon (AXON) Stock Looks Fairly Valued As 149% Run Meets Funding Test
Simply Wall St.9d agoneutral
Axon (AXON) Stock Looks Fairly Valued As 149% Run Meets Funding Test

Axon Enterprise has seen its share price climb a long way over the past few years, yet more recent declines and fresh funding plans now put a sharper focus on what its cash flows really support. With the stock around US$447.76 at the last close, the key issue for readers is whether the current market value lines up with what the business is expected to generate in cash over time. Over the past 5 years the share price has gained 149.1%, which raises the question of how much future cash...

How Investors May Respond To Quanta Services (PWR) Adding AI Cloud Veteran Ellen Rubin To Its Board
Simply Wall St.9d agoneutral
How Investors May Respond To Quanta Services (PWR) Adding AI Cloud Veteran Ellen Rubin To Its Board

Earlier this month, Quanta Services, Inc. appointed Ellen Rubin, an AI and cloud infrastructure veteran and current Operating Partner at Glasswing Ventures, to its Board of Directors, adding experience from Amazon Web Services, multiple enterprise software start-ups, and Allegion’s boardroom. Her background in AI, hybrid cloud, and security could help Quanta align its power infrastructure and utility solutions more closely with the technical needs of data centers and other AI-related...

AngloGold Ashanti (AU) Stock May Trade At A 14% Discount On Cash Flow
Simply Wall St.9d agoneutral
AngloGold Ashanti (AU) Stock May Trade At A 14% Discount On Cash Flow

AngloGold Ashanti has delivered a very strong multi year share price run, and the question now is whether that kind of move is still backed by the cash the business can generate. For anyone looking at the stock today, the issue is less about past gains and more about whether current cash flows can justify paying around US$103 per share. Over the past 5 years the share price has risen by about 7x, which puts a lot of weight on the cash flow story behind AngloGold Ashanti. The business depends...

Could Circle Internet Group (CRCL) Become A Bigger Force In Onchain Finance?
Simply Wall St.9d agoneutral
Could Circle Internet Group (CRCL) Become A Bigger Force In Onchain Finance?

Circle Internet Group (NYSE:CRCL) launched Arc, a purpose-built open Layer 1 blockchain for financial markets, as its public mainnet. Arc integrates Circle's USDC and EURC stablecoins for payments, FX, trading, lending, and asset issuance with dollar-denominated gas fees. The network is backed by an institutional validator set that includes BlackRock, DTCC, Mastercard, Visa, and other financial players. More than 100 ecosystem partners, including banks, payment networks, asset managers,...

Interactive Brokers (IBKR) Turns Every Revenue Dollar Into 77 Cents of Pretax Profit
Insider Monkey9d agoneutral
Interactive Brokers (IBKR) Turns Every Revenue Dollar Into 77 Cents of Pretax Profit

On July 21, Interactive Brokers Group (NASDAQ:IBKR) reported results for the quarter ended June 30, with earnings of $0.69 per diluted share, up from $0.51 a year earlier. Net revenues rose to $1.90 billion from $1.48 billion. That is a big leap for a business that was already highly profitable, and the pretax margin still […]

Infosys (INFY) Lands a Brake Maker as Growth Stays in Low Gear
Insider Monkey9d agoneutral
Infosys (INFY) Lands a Brake Maker as Growth Stays in Low Gear

On August 18, Infosys (NYSE:INFY) announced a long-term deal to manage the enterprise software behind Knorr-Bremse AG, a maker of braking systems for rail and commercial vehicles. The work stretches from ERP and data platforms to engineering and product lifecycle tools, and it runs on Infosys Topaz, the company’s AI offering. It is a nice […]

Forkast News9d agoneutral
Three Frontier Labs Are Building a FINRA-Style Safety Body. History Suggests It Won’t Be a Brake.

September 15, 2026, marked a shift in AI governance when OpenAI Chief Global Affairs Officer Chris Lehane confirmed during a Washington briefing that OpenAI, Anthropic, and Google DeepMind have been coordinating on safety protocols for several weeks. This confirmation moves the industry from abstract discussion toward active coalition-building, though the proposed structure remains unformalized. While […]